NR2F6 and fatty liver disease: As a result, liver TG contents, plasma TG, and hepatic FFA levels were reduced in CD36‐depleted mice in the presence of NR2F6 overexpression (Figure 2K–M), suggesting that NR2F6 cannot promote liver steatosis in the absence of CD36.